Molecular structure of Hyndarin, CAS Number: 2934-97-6
Hyndarin (CAS 2934-97-6)
Alternate Names:
5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-6H- dibenzo[a,g]quinolizine
CAS Number:
2934-97-6
Molecular Weight:
355.43
Molecular Formula:
C21H25NO4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Hyndarin functions as a potent inhibitor of a specific enzyme involved in cellular metabolism. It acts by binding to the active site of the enzyme, preventing its normal function and disrupting the metabolic pathways in which it participates. This disruption ultimately leads to a decrease in the production of key cellular components, affecting the overall cellular function.Hyndarin may interfere with certain signaling pathways within the cell, further contributing to its impact on cellular processes. Its mechanism of action involves specific interactions with key molecular targets, leading to a cascade of effects on cellular function and metabolism. Hyndarin plays a significant role in modulating cellular processes and has the potential to be useful in understanding the mechanisms of cellular metabolism and signaling.
Hyndarin (CAS 2934-97-6) References
- Uncovering Synergistic Mechanism of Chinese Herbal Medicine in the Treatment of Atrial Fibrillation with Obstructive Sleep Apnea Hypopnea Syndrome by Network Pharmacology. | Mao, T., et al. 2019. Evid Based Complement Alternat Med. 2019: 8691608. PMID: 31949472
- Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology. | Xu, W., et al. 2020. Evid Based Complement Alternat Med. 2020: 4086864. PMID: 32148541
- Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis. | Liu, WJ., et al. 2020. J Ethnopharmacol. 257: 112871. PMID: 32325182
- Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking. | Li, J., et al. 2021. Medicine (Baltimore). 100: e27112. PMID: 34941025
- Bioinformatics and Network Pharmacology-Based Approaches to Explore the Potential Mechanism of the Antidepressant Effect of Cyperi Rhizoma through Soothing the Liver. | Lei, Y., et al. 2021. Evid Based Complement Alternat Med. 2021: 8614963. PMID: 35126596
- Network Pharmacology and Molecular Docking Analysis on Molecular Mechanism of Qingzi Zhitong Decoction in the Treatment of Ulcerative Colitis. | Shou, X., et al. 2022. Front Pharmacol. 13: 727608. PMID: 35237152
- Candidate Chinese Herbal Medicine Alleviates Methamphetamine Addiction via Regulating Dopaminergic and Serotonergic Pathways. | Ru, Q., et al. 2022. Front Mol Neurosci. 15: 874080. PMID: 35422687
- Mechanism of Peitu Shengjin Formula Shenlingbaizhu Powder in Treating Bronchial Asthma and Allergic Colitis through Different Diseases with Simultaneous Treatment Based on Network Pharmacology and Molecular Docking. | Zeng, L., et al. 2022. Evid Based Complement Alternat Med. 2022: 4687788. PMID: 35586697
- Network Pharmacology and Data Mining Approach Reveal the Medication Rule of Traditional Chinese Medicine in the Treatment of Premenstrual Syndrome/Premenstrual Dysphoric Disorder. | Qu, S., et al. 2022. Front Pharmacol. 13: 811030. PMID: 35800440
- Identification of Interleukin-1-Beta Inhibitors in Gouty Arthritis Using an Integrated Approach Based on Network Pharmacology, Molecular Docking, and Cell Experiments. | Zeng, L., et al. 2022. Evid Based Complement Alternat Med. 2022: 2322417. PMID: 36193152
- Network pharmacology and experimental studies for deciphering the molecular targets and mechanisms of Chaihu Shugan powder in the treatment of functional dyspepsia. | Wang, Y., et al. 2023. Technol Health Care. 31: 449-462. PMID: 37038797
- Molecular mechanism of modified Huanglian Wendan decoction in the treatment of polycystic ovary syndrome. | Wu, Z., et al. 2023. Medicine (Baltimore). 102: e33212. PMID: 37058016
- Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis | Liu, W. J., Jiang, Z. M., Chen, Y., Xiao, P. T., Wang, Z. Y., Huang, T. Q., & Liu, E. H. 2020. Journal of ethnopharmacology. 257: 112871.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Hyndarin, 500 mg | sc-364763 | 500 mg | $113.00 | |||
Hyndarin, 5 g | sc-364763A | 5 g | $450.00 |